Raymond J. Hohl MD PhD, Principal Investigator and Director
Huaxiang Tong PhD, Research Scientist
Dr. Tong leads the analytical chemistry activities for the group and is responsible for the technologies enabling measurement of the isoprenoid intermediates in biological systems. This includes GC/MS, LC, LC/MS and MS/MS methodologies.
Jeff W. Stevens PhD, Assistant Research Scientist
Dr. Stevens is currently working on pharmaceutical discovery in hard tumors particularly with isoprenoid biosynthetic pathway inhibitors on chondrosarcomas and enchondromas managed in animal and cell culture model systems.
Ella Born, Research Associate
Ms. Born is engaged in all aspects of the general scientific research conducted in the laboratory with a view to producing scientific data contributing to the Investigator's research endeavors.